SFI
SONM icon

Susquehanna Fundamental Investments’s DNA X Inc SONM Stock Holding History

Susquehanna Fundamental Investments’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-58
Closed -$5K – 1463
2022
Q3 		$5K Buy
+58
New +$7.2K ﹤0.01% 1423
2022
Q1 		$50K Hold
326
– – ﹤0.01% 1491
2021
Q4 		$54K Buy
326
+61
+23% +$18.5K ﹤0.01% 1363
2021
Q3 		$129K Buy
+265
New +$201K ﹤0.01% 1599

Other funds holding SONM

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna Fundamental Investments's SONM Position: Q4 2022 in Review

Susquehanna Fundamental Investments sold out of DNA X Inc (SONM) in Q4 2022, closing a stake of 58 shares — an estimated $5K sold.

Susquehanna Fundamental Investments first reported a position in SONM in Q3 2021 and held it in 4 quarters. The position peaked at $129K in Q3 2021. 13 funds tracked by Wall St. Rank hold SONM as of Q4 2022.

  • Susquehanna Fundamental Investments reported no remaining DNA X Inc position as of Q4 2022 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 58 DNA X Inc shares in Q4 2022, an estimated $5K.
  • Susquehanna Fundamental Investments first reported a position in DNA X Inc in Q3 2021 and held it in 4 quarters.
  • Susquehanna Fundamental Investments's DNA X Inc position peaked at $129K in Q3 2021.
  • 13 funds tracked by Wall St. Rank held DNA X Inc as of Q4 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2022, filed 14 Feb 2023.